Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma
GermanyStudy on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation
GermanyStudy on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma
GermanyStudy on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease
GermanyStudy on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
GermanyStudy on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery
GermanyStudy on the Effects of Rituximab for Patients with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
GermanyStudy on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures
GermanyGermanyStudy on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis
GermanyStudy on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.
Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.
Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.
Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.
Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.
Innovative approaches to treating and managing neurodegenerative conditions.
Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.
Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
